Everolimus
Everolimus ATC Code L01EG02 : Antineoplastic and immunomodulating agents - Antineoplastic drugs - Protein kinase inhibitors - Mammalian target of rapamycin (mTOR) kinase inhibitors - Everolimus
Routes | Oral |
---|---|
FDA Approval Date | 2009-03-30 |
Molecular Formula | C53H83NO14 |
Molecular Weight | 958.24 g/mol |
CAS Number | 159351-69-6 |
Brand names | Afinitor, Zortress |